| Breakdown | TTM | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.20M | 38.25M | 37.63M | 41.23M | 41.05M | 36.98M |
| Gross Profit | 20.06M | 16.38M | 17.89M | 17.63M | 20.25M | 17.14M |
| EBITDA | -9.09M | -12.44M | -2.43M | 2.76M | 6.17M | 4.47M |
| Net Income | -11.44M | -14.97M | -6.03M | 272.00K | 4.23M | 2.81M |
Balance Sheet | ||||||
| Total Assets | 36.71M | 41.08M | 49.01M | 54.89M | 50.11M | 43.23M |
| Cash, Cash Equivalents and Short-Term Investments | 620.00K | 733.00K | 609.00K | 2.28M | 9.25M | 10.65M |
| Total Debt | 12.91M | 14.97M | 12.83M | 13.08M | 7.54M | 3.17M |
| Total Liabilities | 20.34M | 24.45M | 20.05M | 19.42M | 14.62M | 11.66M |
| Stockholders Equity | 16.37M | 16.64M | 28.97M | 35.47M | 35.49M | 31.58M |
Cash Flow | ||||||
| Free Cash Flow | 3.05M | -3.52M | 380.00K | -11.86M | -436.00K | 3.79M |
| Operating Cash Flow | 3.62M | -1.55M | 2.01M | -3.52M | 3.54M | 4.71M |
| Investing Cash Flow | -2.63M | -1.74M | -2.69M | -8.34M | -3.97M | -14.06M |
| Financing Cash Flow | -2.88M | 3.61M | -1.19M | 4.88M | -964.00K | 15.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £177.35M | 12.60 | 23.64% | 3.48% | 10.80% | 1.75% | |
70 Outperform | £10.30B | 22.64 | 11.79% | 2.35% | 2.51% | 56.56% | |
67 Neutral | £4.29B | 37.08 | 10.53% | 2.11% | 4.18% | 37.65% | |
56 Neutral | £430.64M | 47.21 | 3.87% | 1.25% | 68.03% | -18.27% | |
52 Neutral | £19.19M | -18.39 | -69.35% | ― | 31.78% | 10.27% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | £4.20M | 77.73 | -16.78% | ― | -4.98% | -114.29% |